Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion type Assertion NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_head.
- NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion description "[Taken together, these results indicate that concomitant inhibition of autophagy is required to increase the therapeutic benefit of AKT inhibition for combination therapy with the standard chemotherapeutic agent cisplatin in advanced skin carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_provenance.
- NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion evidence source_evidence_literature NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_provenance.
- NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion SIO_000772 21351258 NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_provenance.
- NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion wasDerivedFrom befree-20150227 NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_provenance.
- NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_assertion wasGeneratedBy ECO_0000203 NP232660.RALPg6WgvbEluF3K7qd9IvFVerR7Mh5idXWwi-q-TbenA130_provenance.